Sanofi S.A. EO-Medium-Term Nts 2014(14/26)

BID
-
ASK
-
0 Nom.0 Nom.
07/27, 22:00:04 PM

SPREAD (ACT/ REL)- / -
CHANGE COMPARED WITH PREVIOUS DAY (PRICE)0.02%
TODAY'S HIGH (PRICE)99.901
TODAY'S LOW (PRICE)99.881
Week 52 High (Price)99.98
Week 52 Low (Price)0.00

Yield Curves

Type of financial instrument

Corporate Bond

Sub-Type

Health Care

Yield

2.66

Yield spread Bundesanleihe

-0.1673

Tradable for private investors

Minimum amount tradeable unit

100,000.00

Maturity

10/09/2026

Interest Rate

1.75 %

Currency

Euro

Facts & figures

Price data


TRADE PLATFORM	Börse Stuttgart (XSTU)
LAST PRICE / YIELD	99.901 G / 2.66	0 Units
PRICE DETERMINATION TIME	07/27/2026 / 09:46:53 PM
DAILY VOLUME (NOMINAL)	0
YIELD SPREAD	-0.1673
FIXINGPRICE	-
DAILY HIGH / LOW	99.901	99.881
PREV. DAY'S PRICE	99.884	(07/24)
CHANGE DAY BEFORE	+0.02	0.02 %
52 WEEK HIGH / LOW	99.982 (12/15)	0.004 (07/14)

More Price Information

Master Data


WKN	A1ZPB6
ISIN	FR0012146801
SYMBOL	-
EXCHANGE SEGMENT	Freiverkehr
TYPE OF FINANCIAL INSTRUMENT	Corporate Bond
SUB-TYPE	Health Care
ISSUER	Sanofi S.A.
S&P RATING	Please log in to view this field
(TRADING) SEGMENT / TICKS	-/ -
TRADING HOURS	07:30:00 AM - 10:00:00 PM
INTEREST RATE	1.75 %
INTEREST RUN FROM	10/09/2014
NEXT INTEREST PAYMENT	10/09/2026
UNIT INTEREST FROM NOMINAL AMMOUNT	1.544 %


TRADING CURRENCY / NOTATION	Euro/ Percent
NOMINAL CURRENCY	Euro
SETTLEMENT CURRENCY	Euro
QUOTATION	Continuous trading
ISSUING VOLUME	1.51 Bil.
MINIMUM AMOUNT TRADEABLE UNIT	100,000.00
SMALLEST TRADEABLE UNIT	100,000.00
MATURITY	10/09/2026
MARKET MAKER	-
STEP UP/ DOWN WHEN RATING CHANGES	No
STEP UP FIXED AT ISSUE	No
STEP DOWN FIXED AT ISSUE	No
BOND CALLABLE BY THE ISSUER	Yes
BOND IS SUBORDINATED	No

Description

Make Whole Call Option. Callable bond.

Tradability Information

Please log in to see the tradability information for this stock.

Not registered yet? Create your free account here.

Company profile

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.